Israel Biotech Fund
Sol Barer is a Venture Advisor at Israel Biotech Fund. Sol is also the Chairman at Teva and former Chairman and CEO of Celgene (NASDAQ: CELG), which under Dr. Barer’s leadership, developed into one of the world’s largest independent biotech companies.
Dr. Barer currently serves on the board of several Biotech companies including TEVA.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Israel Biotech Fund
Israel Biotech Fund seeks high-value returns by identifying and maximizing the success of therapeutic assets of Israel-based biotech companies. Their key asset is a unique team of 25 Venture Advisors, comprised of renowned industry leaders and professionals who, together with the fund’s managing partners, provide their portfolio companies with hands-on guidance and support.